Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-21-002472
Accepted
2021-06-24 00:16:03
Documents
1
Effectiveness Date
2021-06-23
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 603
  Complete submission text file 9999999995-21-002472.txt   2003
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-256790 | Film No.: 211040481
SIC: 7389 Services-Business Services, NEC